FDA Adverse Event Injury Summary report: N

UNKNOWN ENDO GIA SULU

MDR report key: 12636173 · Received October 14, 2021

Report

Report Number
1219930-2021-04258
Event Type
Injury
Date Received
October 14, 2021
Date of Event
May 26, 2021
Report Date
October 14, 2021
Manufacturer
COVIDIEN LP LLC NORTH HAVEN
Product Code
GDW
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

TITLE: EARLY OUTCOMES AND MID-TERM SAFETY OF ONE ANASTOMOSIS GASTRIC BYPASS ARE COMPARABLE WITH ROUX-EN-Y GASTRIC BYPASS: A SINGLE CENTER EXPERIENCE SOURCE: RECEIVED: 2 JANUARY 2021 / REVISED: 24 MAY 2021 /ACCEPTED: 26 MAY 2021 # THE AUTHOR(S), UNDER EXCLUSIVE LICENCE TO SPRINGER SCIENCE+BUSINESS MEDIA, LLC, PART OF SPRINGER NATURE 2021 OBESITY SURGERY (2021) 31:3786¿3792 HTTPS://DOI.ORG/10.1007/S11695-021-05508-5. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

ACCORDING TO A LITERATURE SOURCE OF STUDY PERFORMED BETWEEN FEBRUARY 2012 AND DECEMBER 2018, WHICH WAS A RETROSPECTIVE STUDY THAT COMPARED THE RESULTS OF PATIENTS UNDERGOING ONE ANASTOMOSIS GASTRIC BYPASS (OAGB) AND ROUX-EN-Y GASTRIC BYPASS (RYGB), ALL PROCEDURES WERE PERFORMED LAPAROSCOPICALLY. IT WAS NOTED THERE WERE 314 PATIENTS; 132 UNDERWENT PRIMARY LAPAROSCOPIC RYGB AND 182 HAD OAGB. A TRI-STAPLER WITH PURPLE OR TAN RELOADS AND A STAPLER FROM A DIFFERENT MANUFACTURER WERE USED FOR THE GASTRIC POUCH, THE GASTRO-JEJUNOSTOMY ANASTOMOSIS AND THE JEJUNO-JEJUNOSTOMY ANASTOMOSIS. COMPLICATIONS INCLUDED: BLEEDING AND MARGINAL ULCER. ONE PATIENT WITH BLEEDING REQUIRED REOPERATION. TWO PATIENTS WITH PERFORATED MARGINAL ULCER REQUIRED REOPERATION. THE AVERAGE LENGTH OF HOSPITAL STAY FOR THE RYGB GROUP WAS 3.58 DAYS AND 4.06 DAYS FOR THE OAGB BATCH. NO OTHER COMPLICATIONS WERE RELATED TO THE DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1528840 UNKNOWN ENDO GIA SULU STAPLE, IMPLANTABLE GDW COVIDIEN LP LLC NORTH HAVEN UNKNOWN ENDO GIA SULU

Patients

Seq Age Sex Outcome Treatment
1 40 YR Hospitalization| R